PMVP
Pmv Pharmaceuticals Inc
Precision oncology company developing p53-targeted therapies
CUSIP: 69353Y103HealthcareUS1 holder
Total Value
$61.16M
Total Shares
1.79M
Net Share Change
-296.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$61.16M1.79M shares
TRIM-296.0K(-14.2%)